There were 2,207 press releases posted in the last 24 hours and 425,597 in the last 365 days.

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of GoHealth, Inc. (GOCO) and Encourages Investors with Losses to Contact the Firm

PHILADELPHIA, Nov. 11, 2022 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating GoHealth, Inc. (“GoHealth”) (NASDAQ: GOCO) on behalf of the Company’s investors.

Since November 2021, shares of GoHealth’s common stock have declined in value from a trading price of approximately $5.00 per share to a current trading price of less than $0.50 per share, a cumulative decline of over 90% in value.

The investigation seeks to determine whether GoHealth and/or the company’s representatives violated the securities laws by issuing false and/or misleading statements and/or failing to disclose material information to GoHealth investors, thereby causing investor losses.

GoHealth stockholders are encouraged to contact Kaskela Law LLC (Adrienne Bell, Esq.) at (484) 229 – 0750, or by email (abell@kaskelalaw.com) or online at https://kaskelalaw.com/cases/gohealth-inc/ , for additional information about this investigation and their legal rights and options.

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com.

CONTACT:

KASKELA LAW LLC
D. Seamus Kaskela, Esq.
Adrienne Bell, Esq.
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 – 1740
(484) 229 – 0750
www.kaskelalaw.com

This notice may constitute attorney advertising in certain jurisdictions.


Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.